Data as of Aug 29
| 0.00 / 0.00%|
The 1 analysts offering 12-month price forecasts for Pharma-Bio Serv Inc have a median target of 2.00, with a high estimate of 2.00 and a low estimate of 2.00. The median estimate represents a +70.94% increase from the last price of 1.17.
The current consensus among 1 polled investment analysts is to Buy stock in Pharma-Bio Serv Inc. This rating has held steady since September, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.